192 related articles for article (PubMed ID: 24136371)
1. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience.
Castagnola E; Bagnasco F; Amoroso L; Caviglia I; Caruso S; Faraci M; Calvillo M; Moroni C; Bandettini R; Cangemi G; Magnano GM; Buffa P; Moscatelli A; Haupt R
Pediatr Infect Dis J; 2014 Mar; 33(3):233-7. PubMed ID: 24136371
[TBL] [Abstract][Full Text] [Related]
2. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study.
Castagnola E; Bagnasco F; Bandettini R; Caviglia I; Morreale G; Lanino E; Giardino S; Moroni C; Haupt R; Faraci M
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1068-73. PubMed ID: 24691219
[TBL] [Abstract][Full Text] [Related]
3. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
4. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.
Blumental S; Mouy R; Mahlaoui N; Bougnoux ME; Debré M; Beauté J; Lortholary O; Blanche S; Fischer A
Clin Infect Dis; 2011 Dec; 53(12):e159-69. PubMed ID: 22080130
[TBL] [Abstract][Full Text] [Related]
5. Phaeohyphomycosis in a tertiary care cancer center.
Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
Omer AK; Ziakas PD; Anagnostou T; Coughlin E; Kourkoumpetis T; McAfee SL; Dey BR; Attar E; Chen YB; Spitzer TR; Mylonakis E; Ballen KK
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1190-6. PubMed ID: 23747459
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
[TBL] [Abstract][Full Text] [Related]
8. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
[TBL] [Abstract][Full Text] [Related]
9. Fungal infections in children with cancer: a prospective, multicenter surveillance study.
Castagnola E; Cesaro S; Giacchino M; Livadiotti S; Tucci F; Zanazzo G; Caselli D; Caviglia I; Parodi S; Rondelli R; Cornelli PE; Mura R; Santoro N; Russo G; De Santis R; Buffardi S; Viscoli C; Haupt R; Rossi MR
Pediatr Infect Dis J; 2006 Jul; 25(7):634-9. PubMed ID: 16804435
[TBL] [Abstract][Full Text] [Related]
10. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ
Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
[TBL] [Abstract][Full Text] [Related]
11. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
[TBL] [Abstract][Full Text] [Related]
12. Pre-emptive diagnosis and treatment of fungal infections--evaluation of a single-centre policy.
Schneider T; Halter J; Heim D; Passweg J; Stern M; Tichelli A; Weisser M; Gerull S
Clin Microbiol Infect; 2012 Feb; 18(2):189-94. PubMed ID: 21729194
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation.
Girmenia C; Ferretti A; Barberi W
Curr Opin Hematol; 2014 Nov; 21(6):459-65. PubMed ID: 25295743
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
[TBL] [Abstract][Full Text] [Related]
15. Triggers for driving treatment of at-risk patients with invasive fungal disease.
Drgona L; Colita A; Klimko N; Rahav G; Ozcan MA; Donnelly JP
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii17-iii24. PubMed ID: 24155142
[TBL] [Abstract][Full Text] [Related]
16. Applicability of the EORTC/MSG criteria for IFD in clinical practice.
Rieger H; Lustig D; Barlow S; Ostermann H; Fiegl M; Peterson L; Rieger CT
Ann Hematol; 2015 May; 94(5):847-55. PubMed ID: 25544029
[TBL] [Abstract][Full Text] [Related]
17. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
[TBL] [Abstract][Full Text] [Related]
18. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.
Groll AH; Castagnola E; Cesaro S; Dalle JH; Engelhard D; Hope W; Roilides E; Styczynski J; Warris A; Lehrnbecher T; ; ; ; ;
Lancet Oncol; 2014 Jul; 15(8):e327-40. PubMed ID: 24988936
[TBL] [Abstract][Full Text] [Related]
19. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
